{"DataElement":{"publicId":"6113696","version":"1","preferredName":"Breast Carcinoma Lymph Node Largest Metastasis Diameter Measurement","preferredDefinition":"Numeric annotation to indicate the largest diameter of lymph node metastases measured in mm.","longName":"BRCA_LN_LRG_METS_DIAM_MSRMT","context":"CCTG","contextVersion":"1","DataElementConcept":{"publicId":"3293778","version":"1","preferredName":"Breast Carcinoma Lymph Node largest Metastasis Diameter","preferredDefinition":"related to the length of a straight line passing through the center of the largest rounded mass of lymphatic tissue to which cancer has first spread from a primary tumor of the mammary organs._A carcinoma arising from the breast, most commonly the terminal ductal-lobular unit.  Breast carcinoma may affect both females and males.  It is the most common malignant tumor and the leading cause of carcinoma death in women.  Risk factors include country of birth, family history, menstrual and reproductive history, fibrocystic disease and epithelial hyperplasia, exogenous estrogens, contraceptive agents, and ionizing radiation.  The widespread use of mammography has contributed in the detection of very early cancerous lesions (less than 2mm in diameter).  The vast majority of breast carcinomas are adenocarcinomas (ductal or lobular).  Breast carcinoma spreads by direct invasion, by the lymphatic route, and by the blood vessel route.  The most common site of lymph node involvment is the axilla.  Breast carcinomas infrequently occur in males (particularly elderly individuals and patients with Klinefelter's syndrome).  The therapy of breat carcinoma includes surgery, radiation therapy, hormonal therapy and chemotherapy, depending on the type and extend of the disease. --2002_A bean-shaped organ surrounded by a connective tissue capsule. It is part of the lymphatic system and is found throughout the body. It is composed predominantly of lymphocytes and its main function is immune protection._Greatest in size of those under consideration._The spread or migration of cancer cells from one part of the body (the organ in which it first appeared) to another. The secondary tumor contains cells that are like those in the original (primary) tumor.","longName":"3293776v1.0:2492778v1.0","context":"NCIP","contextVersion":"1","ObjectClass":{"publicId":"3293776","version":"1","preferredName":"Breast Carcinoma Lymph Node","preferredDefinition":"A carcinoma arising from the breast, most commonly the terminal ductal-lobular unit.  Breast carcinoma may affect both females and males.  It is the most common malignant tumor and the leading cause of carcinoma death in women.  Risk factors include country of birth, family history, menstrual and reproductive history, fibrocystic disease and epithelial hyperplasia, exogenous estrogens, contraceptive agents, and ionizing radiation.  The widespread use of mammography has contributed in the detection of very early cancerous lesions (less than 2mm in diameter).  The vast majority of breast carcinomas are adenocarcinomas (ductal or lobular).  Breast carcinoma spreads by direct invasion, by the lymphatic route, and by the blood vessel route.  The most common site of lymph node involvment is the axilla.  Breast carcinomas infrequently occur in males (particularly elderly individuals and patients with Klinefelter's syndrome).  The therapy of breat carcinoma includes surgery, radiation therapy, hormonal therapy and chemotherapy, depending on the type and extend of the disease. --2002:A bean-shaped organ surrounded by a connective tissue capsule. It is part of the lymphatic system and is found throughout the body. It is composed predominantly of lymphocytes and its main function is immune protection.","longName":"C4872:C12745","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Carcinoma","conceptCode":"C4872","definition":"A carcinoma arising from the breast, most commonly the terminal ductal-lobular unit. It is the most common malignant tumor in females. Risk factors include country of birth, family history, menstrual and reproductive history, fibrocystic disease and epithelial hyperplasia, exogenous estrogens, contraceptive agents, and ionizing radiation. The vast majority of breast carcinomas are adenocarcinomas (ductal or lobular). Breast carcinoma spreads by direct invasion, by the lymphatic route, and by the blood vessel route. The most common site of lymph node involvement is the axilla.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Lymph Node","conceptCode":"C12745","definition":"A bean-shaped organ surrounded by a connective tissue capsule. It is part of the lymphatic system and is found throughout the body. It is composed predominantly of lymphocytes and its main function is immune protection.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AF0A80EE-D2D8-8F00-E040-BB89AD4318EE","latestVersionIndicator":"Yes","beginDate":"2011-10-11","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-10-11","modifiedBy":"ONEDATA","dateModified":"2011-10-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"3793746","version":"1","preferredName":"Largest Metastasis Diameter","preferredDefinition":"Greatest in size of those under consideration.:Cancer that has spread from the organ in which it first appeared to another organ. For example, breast cancer cells may spread (metastasize) to the lungs and cause the growth of a new tumor. When this happens, the disease is called metastatic breast cancer.:Diameter; the length of a straight line passing through the center of a circle and connecting two points on the circumference.","longName":"C25550:C19151:C25285","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Largest","conceptCode":"C25550","definition":"Greatest in size of those under consideration.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Metastasis","conceptCode":"C19151","definition":"The spread or migration of cancer cells from one part of the body (the organ in which it first appeared) to another. The secondary tumor contains cells that are like those in the original (primary) tumor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Diameter","conceptCode":"C25285","definition":"The length of a straight line passing through the center of a circle or sphere and connecting two points on the circumference.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E000DB7A-9434-9ACC-E040-BB89AD4365BE","latestVersionIndicator":"Yes","beginDate":"2013-06-25","endDate":null,"createdBy":"ZIEGLERK","dateCreated":"2013-06-25","modifiedBy":"ONEDATA","dateModified":"2013-06-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008549","version":"1","preferredName":"Involvement and Extent of Disease","preferredDefinition":"indication of the presence and extent of disease.","longName":"INV_AND_EXT_OF_DZ","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22AA815-A017-5261-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AF0A80EE-D2E6-8F00-E040-BB89AD4318EE","latestVersionIndicator":"Yes","beginDate":"2011-10-11","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-10-11","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":"updated for ISO compliance","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"6113695","version":"1","preferredName":"Millimeter Measurement","preferredDefinition":"Annotation used to indicate the size or magnitude of something that was determined by comparison to a standard.","longName":"6113695v1.0","context":"CCTG","contextVersion":"1","type":"Non-enumerated","dataType":"NUMBER","unitOfMeasure":"mm","minLength":"1","maxLength":"4","minValue":null,"maxValue":null,"decimalPlace":"1","format":"99.9","PermissibleValues":[],"ConceptualDomain":{"publicId":"2008549","version":"1","preferredName":"Involvement and Extent of Disease","preferredDefinition":"indication of the presence and extent of disease.","longName":"INV_AND_EXT_OF_DZ","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22AA815-A017-5261-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2184312","version":"1","preferredName":"Measurement","preferredDefinition":"Measurement; the size or magnitude of something.","longName":"C25209","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Measurement","conceptCode":"C25209","definition":"Annotation used to indicate the size or magnitude of something that was determined by comparison to a standard.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"DB6C8AC6-1DB1-3E75-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-05-27","endDate":null,"createdBy":"SBREXT","dateCreated":"2004-05-27","modifiedBy":"DWARZEL","dateModified":"2006-10-26","changeDescription":"Move to caBIG context as teh preferred Rep class for Measurement","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"66D24FDC-1885-68D2-E053-F662850A5FF7","latestVersionIndicator":"Yes","beginDate":"2018-03-07","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-03-07","modifiedBy":"TAYLORT","dateModified":"2018-11-26","changeDescription":"11/26/18 TT released/CWinch. 3/7/18 tt/MA39.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[{"name":"BRCA_LN_LRG_METS_DIAM_MSRMT","type":"USED_BY","context":"CCTG"}],"ReferenceDocuments":[{"name":"Measurement of largest metast","type":"Preferred Question Text","description":"Measurement of largest metastases","url":null,"context":"CCTG"}],"origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"66D26E73-34F7-6D82-E053-F662850AC6B1","latestVersionIndicator":"Yes","beginDate":"2018-03-07","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-03-07","modifiedBy":"TAYLORT","dateModified":"2018-11-26","changeDescription":"11/26/18 TT released/CWinch. 3/7/18 tt/MA39.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}